Last CNY42.80 CNY
Change Today 0.00 / 0.00%
Volume 0.0
300142 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 09/10/14 All times are local (Market data is delayed by at least 15 minutes).

walvax biotechnology co-a (300142) Snapshot

Open
CNY42.74
Previous Close
CNY42.80
Day High
CNY43.05
Day Low
CNY42.40
52 Week High
02/25/14 - CNY43.95
52 Week Low
11/1/13 - CNY25.92
Market Cap
10.0B
Average Volume 10 Days
950.6K
EPS TTM
CNY-0.38
Shares Outstanding
234.0M
EX-Date
05/30/14
P/E TM
--
Dividend
CNY0.04
Dividend Yield
0.09%
Current Stock Chart for WALVAX BIOTECHNOLOGY CO-A (300142)

Related News

No related news articles were found.

walvax biotechnology co-a (300142) Related Businessweek News

No Related Businessweek News Found

walvax biotechnology co-a (300142) Details

Walvax Biotechnology Co., Ltd., a biological pharmaceutical company, is engaged in the research and development, production, and sale of bio-medicine products in the People’s Republic of China. It provides bio-medicines, such as vaccines, blood products, and others. The company offers Group A and C meningococcal polysaccharide vaccine for children and adults over the age of 2 years to prevent disease caused by the bacteria named neisseria meningitidis groups A and group C; and haemophilus influenzae type b conjugate vaccine for infants from the age of 2 months to 5 years to induce immunization against infectious diseases, such as meningitis, pneumonia, septicemia, cellulitis, arthritis, and epiglottitis, etc. It also provides prefilled syringe dosage form of haemophilus influenzae type b conjugate vaccine; Group A, C meningococcal polysaccharide conjugate vaccine for infants from the age of 3 months to 5 years preventing diseases, such as cerebrospinal meningitis and septicemia; and Group ACYW135 meningococcal polysaccharide vaccine for children above 2 years old to prevent meningococcal disease caused by epidemic Neisseria meningitidis serogroups A, C, Y, and W-135. The company was founded in 2001 and is headquartered in Kunming, the People’s Republic of China.

Founded in 2001

walvax biotechnology co-a (300142) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

walvax biotechnology co-a (300142) Key Developments

Walvax Biotechnology Co.,Ltd Approves Amendments to its Articles of Association

Walvax Biotechnology Co.,Ltd approved amendments to its Articles of Association at its EGM held on August 27, 2014.

Walvax Biotechnology Co.,Ltd Proposes Amendments to its Articles of Association

Walvax Biotechnology Co.,Ltd at its Extraordinary General Meeting to be held on 27 August 2014, to consider Amendments to the company's articles of association.

Walvax Biotechnology Co.,Ltd, Special/Extraordinary Shareholders Meeting, Aug 27, 2014

Walvax Biotechnology Co.,Ltd, Special/Extraordinary Shareholders Meeting, Aug 27, 2014., at 10:00 China Standard Time. Agenda: To consider the eligibility and scheme for non-public share offering to specific parties; to preplan, analysis report and analysis report for non-public share offering; to consider report on use of previously raised funds; to consider connected transactions involved in the non-public share offering; to sign conditional share subscription agreement with subscription targets; to consider plan for the shareholders profit return for the next three years(2014-2016); to consider commitment letter on diluted immediate returns for the non-public share offering and profit distribution; to consider amendments to the company's articles of association; to set up a special account for the raised fund; to consider amendments to the company's rules of procedures governing shareholders' general meetings; and to consider the authorization to the board to handle matters in relation to non-public share offering.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300142:CH CNY42.80 CNY 0.00

300142 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300142.
View Industry Companies
 

Industry Analysis

300142

Industry Average

Valuation 300142 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 13.7x
Price/Book 3.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 9.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WALVAX BIOTECHNOLOGY CO-A, please visit www.walvax.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.